Carbetocin Injection Market Research Report 2021-2027 | Share, Global Trends, Key Players, Growth Analysis

The Carbetocin Injection Market size is expected to grow at an annual average of 5% during 2021-2027. Carbetocin is a drug used to control postpartum bleeding – bleeding after childbirth. It has a similar action to oxytocin and has a similar action to oxytocin, which induces uterine contractions. According to CIC Edizioni Internazionali, nearly 500,000 women die each year from this potentially preventable cause, and a quarter of these deaths result from bleeding during delivery. Carbetocin was first described in 1987 as a long-acting synthetic oxytocin analogue, 1-deamino-1-monocarbo-(2-O-methyltyrosine)-oxytocin. A single dose of carbetocin was hypothesized to act as a 16-hour intravenous oxytocin infusion. It is about increasing uterine tone and reducing the risk of PPH in elective cesarean section.

The following segmentation are covered in this report:

By Application

• Hospitals
• Clinics
• Other

By Type

• Original Drug
• Generic Drug

Company Profile

• Ferring Pharmaceuticals
• Boya Bio
• Hybio Pharmaceutical
• Beacon Pharmaceuticals Ltd.
• Chengdu Shengnuo Biotechnology
• Pfizer
• Tibet Aim Pharm Inc (Aim Pharm)

Scope of the report

The research study analyses the Carbetocin Injection Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Carbetocin Injection Market Report

• What was the Carbetocin Injection Marketsize in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Carbetocin Injection Marketwas the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.